Home > Balance Sheet > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Non-Current Liabilities

    Back to Balance Sheet
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2013Mar2012
Total Non-Current Liabilities ₹7.87 Cr₹3.19 Cr₹3.28 Cr₹1.79 Cr₹1.32 Cr

What is the latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) ?

The latest Total Non-Current Liabilities ratio of NATH BIOGENES (INDIA) is ₹7.87 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹7.87 Cr
Mar2023₹3.19 Cr
Mar2022₹3.28 Cr
Mar2013₹1.79 Cr
Mar2012₹1.32 Cr

How is Total Non-Current Liabilities of NATH BIOGENES (INDIA) Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹7.87 Cr
146.55
Mar2023 ₹3.19 Cr
-2.60
Mar2022 ₹3.28 Cr
82.96
Mar2013 ₹1.79 Cr
35.20
Mar2012 ₹1.32 Cr -

Compare Total Non-Current Liabilities of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹302.1 Cr -5.6% 1.9% -16.4% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,295.0 Cr -0.8% 6.7% 26.7% Stock Analytics
KAVERI SEED COMPANY ₹7,349.6 Cr -8.1% 12.8% 87.4% Stock Analytics
VENKYS (INDIA) ₹2,392.0 Cr -1.6% 1% -2.2% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,429.6 Cr -12.8% 8.2% -36.7% Stock Analytics
INDO US BIOTECH ₹340.9 Cr -1.9% 8.4% -29.5% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

-5.6%

1.9%

-16.4%

SENSEX

0.8%

3.8%

8.4%


You may also like the below Video Courses